Introduction
The research on degradable magnesium alloys (and its synonyms) as implant materials had started in 1900s-1920s [1, 2] . However, since the development of bio-stable metallic implants had matured, the investigation of bio-corrodible metallic implants had become unpopular [3] . Renewed interest of degradable / resorbable metallic implants had recently emerged in the fields of bone fixation device, cardiovascular stent and tissue engineering scaffold [3] [4] [5] [6] [7] [8] [9] .
Magnesium is itself considered relatively safe [3] , however the alloying elements such as aluminum, zinc and manganese are well-known to carry substantial toxicological concerns [10] [11] [12] . There appears increased evidence suggesting that Al is a risk factor for Alzheimer's disease [13] [14] [15] despite oppositions were not lacking [11, 16] , but even so it is still unsure whether Al would be the sole factor [13] . Toxicological limit of this element was already developed based on its neurotoxicity, which should logically occur at lower dose than Alzheimer's disease which is a more severe form of neurological disorder. Mn is also found to affect the nervous system [12, 17] . Unfortunately, it appeared to be a trend that journals on biomaterials tend to focus on the structure, properties and functions [18] .
Toxicological risk assessment is a gold standard adopted by most public health agencies, governments and institutions all over the world on assessing the risk of exposure for various potentially harmful biological or chemical substances to humans [10] [11] [12] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ], yet to date we could not identify any attempt made by other current researchers on the quantitative toxicological risk of magnesium alloys as a biomedical implant. For an assessment of implants intended for human application, NOAEL is more appropriate than LD 50 , as the latter utilizes lethality as the end point thereby ignoring non-lethal health effects occurring at much lower exposure levels. Current animal studies focused on localized biocompatibility around the implant site [9, 35, 36] and did not specifically target on other potential toxicological effects that could occur, probably after a longer duration than the experiments. Without proper toxicological assessment on systemic effects, it would be impossible for any novel biomedical implant to obtain regulatory approval in a developed country, and the loss of investment could be tremendous. As a result, during an early stage of implant development, it is important to ensure that an implant composition should not pose significant health risk to human, at least theoretically, when used at a mass typical for an intended application.
Therefore, we have conducted a theoretical risk assessment to compute the lowest mass ACCEPTED MANUSCRIPT 5 of implant sufficient to result in any adverse side effect in some human. The toxicological issues of common alloying elements in ten standard magnesium alloys were considered based on the toxicological data from authoritative public health agencies, and the impact of the results were discussed.
This article aims to remind researchers on degradable metallic implants on the potential systemic toxicological risk of this class of implant (or any new class of biomaterial), and to attract attention of toxicologists on this matter. The focus of the current risk assessment is the threshold implant mass, which reflects the theoretical maximum mass of such biomaterial that might be safely implanted into a patient; while a judgment on the relative severity of specific adverse effects is outside the scope of this article.
Methodology
Toxicological information on critical studies of oral exposure limits were obtained from authoritative public health agencies: Agency for Toxic Substances and Disease Registry approach for dose-response assessment was adopted [37] . Intermediate-term NOAEL was adopted whenever available. The uncertainty factors (UFs) assigned by the toxicologists in the agencies to address for the interspecies and inter-individual differences (human variability) would continue to be adopted, unless there were strong reasons for the opposition. In general, the UFs were derived in concordance with WHO guideline [37] .
ASTM upper abundance limits were adopted as the abundance of component elements inside the alloys [38] [39] [40] . Gastrointestinal absorption efficiencies were obtained from ATSDR and FSA in order to adjust the exposure limits to account for an assumed 100% absorption. 60kg body weight and 365 days of even corrosion were arbitrarily chosen to represent a normal person and a degradation period reasonable for common applications.
Relevant computations were expressed by the following equations:
Equation 1
Raw Tolerable Exposure of a specific element (TE-r) for human, in mg/kg/day
Equation 2
Absorption-adjusted Tolerable Exposure (TE-aa) of a specific element = TE-r x absorption efficiency from oral route
Equation 3
Reference annual exposure (RAE) of a specific element for a 60kg adult (in mg/yr) = TE-aa x 60 x 365 = 21900 x TE-aa To determine the reference annual exposure of an alloy, the element-specific RAE of each element in an alloy was then divided by its maximum abundance in the alloy. The resultant reference value, now defined as Abundance-Adjusted Reference Annual Exposure (AARAE), would be equal to the component-specific threshold alloy mass when this component element was assumed the sole source of adverse effects.
Equation 4
Abundance-Adjusted Reference Annual Exposure (AARAE) = RAE / abundance of the specific component element
The lowest AARAE among component elements for a given alloy would then indicate the lowest alloy mass sufficient to produce an adverse effect, as an implant to be completely 
Results
Literature data for the toxicological critical values of common elements in magnesium alloys and the corresponding toxicological effects are listed in Table 1 , upper abundance limits of component elements in the magnesium alloys listed in Table 2 , and the derived toxicological data for ten magnesium alloys are listed in Table 3 . n/a n/a 102 K1A n/a n/a n/a While it might appear to engineering researchers that the tolerance for Al is low because an uncertainty factor of 10 x 10 = 100 was utilized, it must be noted that safety would always be the primary concern to any biomedical implant, and the uncertainty factor was specifically adopted: 10 for extrapolation of animal data to human and 10 to account for interindividual variability; therefore well-justified on a public health perspective [11, 37] .
Any loosening of the standard practice could leave vulnerable patients at risk.
It may also be observed from Table 1 that no authoritative NOAEL or similar values were identified for some of the alloying elements, such as rare earth metals or zirconium. This should however be considered as a lack of sufficient information only, and it would be conceptually wrong to consider that something is safe "because of" an insufficiency of data resulted from experimental deficiencies. For example, as in the case of cerium (a rare earth metal), "an RfD for cerium was not derived because the available studies were not suitable for quantitation of effects for various reasons…" according to IRIS [41] .
A report by TERA in 1999 [45] had suggested oral RfDs for soluble chlorides of three rare earth elements, at 0.004mg/kg/day to 0.03mg/kg/day based on decreased body weight;
however the confidence of the oral RfDs in this report was "medium to low" (original wording, page 23), and the lack of reviewed data on gastrointestinal absorption of individual rare earth metals disallowed an extrapolation of toxicological data to a 100% absorption scenario. Moreover, a decrease in body weight could probably result from gastrointestinal effects, thus this end point might not be applicable for assessing a degradable metallic implant. Despite an insufficiency of data, the report also summarized systemic toxicological symptoms identified by Haley et al. [46] [47] [48] [49] [50] , such as respiratory paralysis and impaired locomotion caused by acute intraperitoneal exposure of common rare earth metals, and perinuclear vacuolization of liver cells caused by sub-chronic oral exposure. Adverse effects of rare earth metals [51, 52] and zirconium [42, 43] were also well-documented in other articles and their references. The derived tolerable mass for ZK61A, EZ33A, WE54A, WE43A and K1A, which carry Zr and RE metals, should therefore be considered as for reference only; being data-deficient instead of carrying exceptionally low toxicity.
As for any theoretical or experimental assessment, it should also be noted that this model carries some limitations. For example, the oral and potentially inhalational intake of the metals from daily activities, which could be considerable for some elements [10-12, 17, 24, 25, 28, 53] , were not taken into account. Logically, when such intake occurs, the tolerable mass should be reduced. This factor might be offset when the degradation time is increased, to the limit that the period does not exceed three years as specified by ASTM [54] for a degradable implant.
On the other hand, this model could potentially overcast the systemic toxicological concern if the corrosion products of the metals could not dissolve well in the body. Under this condition, however, the existence of such undissolved foreign material particles or accumulated ions would create remaining symptoms [55] , foreign body response [56, 57] or other localized effects that could require surgical interventions, and in such case it would be arguable for whether it's appropriate to continue calling it a "resorbable" implant (although the implant would inarguably be completely "degradable" in the sense of mechanical integrity).
Interactions of different metals and metal ions were also omitted from our assessment.
For a pioneering theoretical assessment, it could only be assumed that corrosion would be even, and the release of different metal ions during degradation would also be even; however this is unlikely for a degradable implant in reality. In the body, the release of metal ions, as in any case of corrosion, is expected to be non-linear and multifactorial, affected by engineering parameters such as grain size, manufacturing process, shape, size and surface area of the implant; or non-engineering factors such as pH, ion concentrations, fluid content and pressure at the implant site; plus the often-forgotten yet significant effect of peri-implant fibrous tissues and gas bubbles [58] ; although instantaneous On a related note, while magnesium was erroneously considered by many researchers as "non-toxic" [3, 59, 60] , its adverse effects had long been documented [28, 44] , and cases of lethality caused by soluble magnesium ions on otherwise healthy individuals were reported [61] [62] [63] [64] . The tolerable daily intake of magnesium as food was set at 350-400mg/day [28, 44] for guidance purpose, and the bioavailability of magnesium is about 50% [28] , translating into a tolerable mass of implant at 64-73g/year, assuming no intake of magnesium from other routes. Non-fatal, non-gastrointestinal adverse effect due to magnesium (as nausea and hypermagnesaemia) could occur, and diarrhea caused by magnesium overdose is at least partially non-osmotic according to current evidence on its linkage with nitric oxide synthase . Although diarrhea alone is seldom fatal, it can definitely affect the living standard of a patient, and the resultant dehydration and ion imbalance might lead to increased fatality when associated with other diseases and conditions.
This pioneering risk assessment model should not be considered as a perfect one, and it had been subjected to refinements [66, 67] . Toxicological data might also be overridden by newer, more sophisticated experiments. As the research on degradable metallic implants becomes more popular and metal ions from industrial waste continue to pose health threat to mankind, it is expected that more toxicological studies will be conducted, and international joint programs such as the International Program of Chemical Safety run by WHO, ILO and UNEP[68], or hopefully an establishment of a toxicological database on metals similar to the scale of IPCS, will provide peer-reviewed and updated toxicological guidance limits of metals in the future, so that toxicological risk assessments could be conducted without excessive reliance on data from governments.
The dose of a given substance is an important factor to toxicological effects [69] . Even pure water can kill at a sufficiently high dose [70, 71] . Despite engineering advancements, researchers must realize that degradable metallic implant is not a class of totally inert material, and degradation products do get into the body. As metal ions are released when degradation occurs, it does carry potential side effects that truly require adequate interdisplinary attention, and cooperation, among engineers, medical doctors, biochemists, medical researchers on toxicology, orthopedics, cardiology, neurology and other areas, plus public health agency officers, before an implant made this class of biomaterial can be considered safe for human use at a considerable dose, i.e. volume.
Conclusion
In this article, dose-response assessment was conducted to derive tolerable limits for alloys that could potentially be adopted as degradable metallic implants. It was found that the limiting factor for the tolerable implant masses of common magnesium alloys was usually aluminum, and the tolerable mass of such alloys at below or around 1 gram per year might be inadequate for applications such as larger internal fixation devices of bone fracture. However, for some component elements such as zirconium and rare earth metals, reliable theoretical assessment could not yet be performed due to a deficit of toxicological data, and toxicological studies should be conducted in the future for such elements to ensure the safety on their use in degradable biomedical implants.
Statement on the impact
Current researchers on degradable metallic implants sometimes study in vivo models or with cell line, but it appears that the majority of articles are on degradable magnesium implants mainly focus on corrosion control and mechanical properties. Even for the in vivo models, it appeared that their focus was the localized effects. Insufficient attention was paid to potential systemic adverse effects, and some researchers even assumed magnesium alloys to be completely non-toxic. This is very dangerous, as nothing is totally non-toxic.
This short article utilized the methodology of dose-response assessment, adopted by World Health Organization and most public health agencies, to state the important issue of potential metal toxicity in degradable metallic implant. The possibility of remnant particles after degradation is also briefly discussed.
By attracting the attention of toxicologists, it is hoped that future researchers will be more aware of the toxicological issues of alloying elements, to ensure that future implants will at least be theoretically tolerable to the body.
